Anti-BST2/Tetherin antibody [EPR20202-150]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal BST2/Tetherin antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 10 publications.
View Alternative Names
CD317, Bone marrow stromal antigen 2, BST-2, HM1.24 antigen, Tetherin, BST2
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling BST2/Tetherin with ab243230 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (Green). Confocal image showing cytoplasmic staining in HeLa cells (PMID : 20529266).
The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized U-937 (human histiocytic lymphoma cell line) cells labeling BST2/Tetherin with ab243230 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (Green). Confocal image showing cytoplasmic staining in U-937 cells (PMID : 20529266).
The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.
- Flow Cyt
Unknown
Flow Cytometry - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
Flow cytometric analysis of HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling BST2/Tetherin with ab243230 at 1/700 dilution (Red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.
- IP
Unknown
Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
BST2/Tetherin was immunoprecipitated from 0.35 mg HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab243230 at 1/40 dilution. Western blot was perfromed on the immunoprecipitate using ab243230 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used afor detection at 1/5000 dilution.
Lane 1 : HeLa whole cell lysate 10 μg (input)
Lane 2 : ab243230 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab243230 in HeLa whole cell lysate.
Blocking and dilution buffer and concentration : 5% NFDM/TBST
Exposure time : 3 seconds.
All lanes:
Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230)
Predicted band size: 20 kDa
false
- WB
Lab
Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
Lanes 1 - 4 : Merged signal (red and green). Green - ab243230 observed at 30 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.
ab243230 was shown to react with BST2/Tetherin in wild-type HeLa cells in Western blot with loss of signal observed in BST2 knockout samples. Wild-type HeLa and BST2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab243230 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Bst2 knockout HeLa cell lysate at 20 µg
Lane 3:
Wild-type A431 cell lysate at 20 µg
Lane 4:
BST2 knockout A431 cell lysate at 20 µg
Predicted band size: 20 kDa
Observed band size: 30 kDa
false
- WB
Unknown
Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 19196977; PMID : 19737401).
BST2/Tetherin is a glycosylated protein, its calculated MW is 20 kDa, and the observed MW is 35 kDa, which is consistent with the literature.
Both 35 and 70 kDa bands were detected under the reducing condition, whereas under the non-reducing condition, only the 70 kDa band was detected.
All lanes:
Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate in the loading buffer containing DTT at 20 µg
Lane 2:
HeLa whole cell lysate in the loading buffer without DTT at 20 µg
Lane 3:
K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate in the loading buffer containing at 20 µg
Lane 4:
K562 whole cell lysate in the loading buffer without DTT at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 20 kDa
Observed band size: 35 kDa,70 kDa
false
Exposure time: 48s
- WB
Unknown
Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
Blocking/Diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230) at 1/1000 dilution
All lanes:
U-937 (human histiocytic lymphoma cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 20 kDa
false
Exposure time: 125s
Related conjugates and formulations (2)
-
Anti-BST2/Tetherin antibody [EPR20202-150] - BSA and Azide free (Capture)
-
Anti-BST2/Tetherin antibody [EPR20202-150] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Journal of extracellular vesicles 14:e70122 PubMed40704538
2025
Applications
Unspecified application
Species
Unspecified reactive species
Infectious agents and cancer 20:36 PubMed40514669
2025
Applications
Unspecified application
Species
Unspecified reactive species
Genome medicine 16:148 PubMed39696540
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer gene therapy 32:38-50 PubMed39558134
2024
Applications
Unspecified application
Species
Unspecified reactive species
Memorias do Instituto Oswaldo Cruz 119:e240102 PubMed39476027
2024
Applications
Unspecified application
Species
Unspecified reactive species
EMBO reports 24:e57224 PubMed37818801
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature 622:562-573 PubMed37673118
2023
Applications
Unspecified application
Species
Unspecified reactive species
bioRxiv : the preprint server for biology : PubMed33442692
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell stem cell 29:1346-1365.e10 PubMed36055191
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1459 PubMed34737799
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com